ABEO Sep 2024 2.500 call
| Previous close | 2.4000 |
| Open | 2.8500 |
| Bid | 0.1000 |
| Ask | 2.3500 |
| Strike | 2.50 |
| Expiry date | 2024-09-20 |
| Day's range | 2.4000 - 3.1800 |
| Contract range | N/A |
| Volume | |
| Open interest | 338 |
GuruFocus.comInsider Sale: Director Christine Silverstein Sells Shares of Abeona Therapeutics Inc (ABEO)
On June 18, 2024, Christine Silverstein, Director of Abeona Therapeutics Inc (NASDAQ:ABEO), executed a sale of 25,821 shares of the company. Following this transaction, the insider now owns 62,063 shares of Abeona Therapeutics Inc. Abeona Therapeutics Inc (NASDAQ:ABEO) is a biopharmaceutical company focused on developing gene and cell therapies for life-threatening rare genetic diseases.
GlobeNewswireAbeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CLEVELAND, June 03, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4). On May 31, 2024, the Compensation Committee of Abeona’s Board of Directors granted restricted stock equity awards as a material inducement to employment to three individuals hired by Abeona, which equity awards relate to, in the agg
- GlobeNewswire
Abeona Therapeutics to Present at the Jefferies Global Healthcare Conference
CLEVELAND, May 28, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that members of its senior management team will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 11:30 a.m. Eastern Time. The Company will also participate in one-on-one investor meetings at the conference. A live webcast of the fireside chat will be available on the Investors section of the Abeona website under "Events" at https://investors
